PubMed Health⌕ Search

Biomedical subjects

T Kusaba

Publications and source records attributed to T Kusaba.

At least 55 records · Page 3Linked to original sources
PubMed1986

[Clinical studies on the transference of cephem-type antibiotics into bile and gallbladder tissues with special reference to cefotiam and cefmenoxime].

Cefotiam (CTM) and cefmenoxime (CMX) were studied for their serum concentrations and transference into bile in patients with PTCD or T-tube. One gram of CTM or either 1 g or 2 g of CMX was administered by an intravenous drip infusion for over 30 minutes. These drugs were also studied for their serum concentrations, bile concentrations, and tissue concentrations in the walls of the gallbladder of patients operated on for cholelithiasis. Intravenous drip infusion (over 30 minutes) was used to administer 1 g of CTM or 1 g or 2 g CMX immediately before surgery. Both CTM and CMX were readily transferred into bile. Their bile concentrations, however, varied greatly among patients, and extremely low levels were detected in some patients. A crossover analysis of concentrations of CMX in bile of patients given doses of 1 g and 2 g revealed a dose-response relationship. The crossover analysis of drug concentrations in bile of patients given CTM and CMX showed that CMX is transferred more readily to bile. The relationship between liver functions and drug transfer to bile was examined by plotting the total bilirubin level against drug concentrations in bile. The plots formed an exponential curve with a correlation coefficient (r) being -0.52 in cases when each subjects received 1 g of CTM and -0.72 in cases when each subjects received 1 g of CMX. A study of 3 patients given CMX at a dose of 1 g suggested that bile levels of CMX may be correlated to ICG. Concentrations of CTM and CMX in tissues of the gallbladder wall were fairly high, with unexpectedly small variance among patients. Even in patients with low bile concentrations of these drugs, drug levels in the tissues of the gallbladder wall were high. Drug levels in the noninflammatory tissues were higher than those in inflammatory lesions. The above findings suggest that CTM should be the antibiotic of choice for patients with ordinary biliary tract infections and after the surgery of the liver and biliary tract system, while CMX should be the antibiotic of choice for patients with severe biliary tract infections, and for compromised hosts after the surgery of the liver and biliary tract system.

Aged↗
PubMed1985

B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.

We have examined the ability of B cells from patients with systemic lupus erythematosus (SLE) to form colonies in vitro. Significantly more B cell colonies growing in the absence of irradiated T cells were observed in patients with active SLE. Helper T cell function of active SLE was normal. Culture supernatants of SLE T cells had significantly less activity to support the B cell colony formation. Our results suggest that the hyperactivity of B cells in SLE may reside in the lupus B cells themselves and that SLE T cells are defective in releasing the soluble factor.

Adolescent↗
PubMed1985

The role of peripheral blood T and B lymphocytes in mitogen responses during human pregnancy.

Studies on the role of T and B lymphocytes of pregnant and post-partum women were performed in a pokeweed mitogen (PWM) stimulated culture system. The responses were assessed by immunofluorescent staining for intracytoplasmic immunoglobulins and solid-phase radioimmunoassay for Ig secretion into culture supernatants. As compared with non-pregnant control subjects, a slight decrease of helper T cell function and accelerated suppressor activity of T cells in pregnant and post-partum women in B cell differentiation promoted by PWM were demonstrated. Conversely, B lymphocytes in pregnant and post-partum women were hyperreactive in the presence of T lymphocytes from non-pregnant control subjects in the mitogen stimulated culture system.

Antibodies, Monoclonal↗
PubMed1984

Characterization of monoclonal antibodies against etiological agents of Weil's disease.

Monoclonal antibodies against etiological agents of Weil's disease were produced by cell fusion technology. Twenty hybridomas were produced through the fusion of P3X63Ag8 .653 cells with spleen cells from BALB/c mice immunized against Leptospira interrogans serovar icterohaemorrhagiae RGA strain and serovar copenhageni Shiromizu and M20 strains. Reactivities of the antibodies produced by the hybridomas were determined by the microscopic agglutination test. Among the five hybridoma antibodies to the RGA strain, two reacted specifically to serovar icterohaemorrhagiae, two reacted to serovar icterohaemorrhagiae at a high titer and serovar copenhageni at a low titer, and one reacted to serovars icterohaemorrhagiae, copenhageni, pyrogens, and canicola. Of the ten hybridoma antibodies to the Shiromizu strain, one reacted specifically to serovar copenhageni, seven reacted to both serovars copenhageni and icterohaemorrhagiae at almost the same titer, and two exhibited intermediate properties. Of the five hybridoma antibodies to the M20 strain, three reacted to both serovars copenhageni and icterohaemorrhagiae at almost the same titer, one reacted to serovar copenhageni at a low titer and serovar icterohaemorrhagiae at a high titer, and one reacted to serovars copenhageni, icterohaemorrhagiae, and pyrogens. The results revealed that each serovar has its own antigen(s) and their common antigens. In addition, 20 strains of leptospires were recently isolated and tested with three monoclonal antibodies characterized by different reactivities. Twenty strains were clearly identified by their antibodies, i.e., 16 strains were identified as serovar icterohaemorrhagiae and three strains were identified as serovar copenhageni. The remaining strain, which was not agglutinated by three antibodies, was identified as serovar autumnalis by an agglutination test with immune rabbit sera.

Agglutination↗
PubMed1984

Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies.

Hybridoma cells were produced by fusing P3X63Ag8.653 mouse myeloma cells with spleen cells from BALB/c mice immunized with Japanese encephalitis (JE) virus, Nakayama-RFVL strain. The resulting 26 clones produced hemagglutination inhibition antibodies against the homologous strain. The hemagglutination inhibition reactivity of each clone was tested against six flaviviruses: JE, Murray Valley encephalitis (MVE), Egypt 101 strain of West Nile (WN), St. Louis encephalitis (SLE), Russian spring summer encephalitis, and dengue type 1. The 26 monoclonal antibodies fell into four groups: 14 JE species-specific antibodies, 6 antibodies reactive to JE and MVE viruses, 3 antibodies to three or four viruses in the JE-MVE-WN-SLE subgroup, and 3 antibodies to all six flaviviruses. Furthermore, antigenic comparison of 27 strains of JE virus was carried out by using five JE species-specific monoclonal antibodies. Of these, 24 strains were isolated in various parts of Japan, and 3 strains came from Southeast Asia. In reactivity, the 27 strains were classified into at least four antigenic groups. The results showed that the Nakayama-Yakken strain is a mutant strain which lacks the Nakayama strain-specific antigen and that the recently isolated strains are immunologically different from Nakayama and JaGAr 01 strains. One clone (NARMA 13) produced a JE species-specific antibody which showed almost the same titer against 26 JE virus strains, whereas one clone (NARMA 5) produced a Nakayama strain-specific antibody which reacted only to the Nakayama-RFVL and Nakayama-Yoken strains.

Animals↗
PubMed1983

Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, Japan.

Between 1968 and 1981, a total of 1955 serum samples from healthy subjects chosen at random in seven districts of Okinawa and two districts of Kyushu were surveyed for antibody to hepatitis A virus (anti-HAV) by radioimmunoassay. Overall prevalence of anti-HAV was 55.1% in Okinawa and 35.9% in Kyushu. Prevalence of less than 10% was observed in subjects less than or equal to 14 years of age in Okinawa and less than or equal to 24 years of age in Kyushu. In three of the districts of Okinawa, second serum samples were collected after intervals of eight, 10, and 12 years, respectively. Overall prevalence of anti-HAV decreased significantly over these time periods. When the age-specific prevalence of anti-HAV on the first occasion is compared with that on the second occasion, it can be seen that there have been few new cases of hepatitis A infection. These data suggest that hepatitis A infection among children has declined dramatically in recent years, and that young people may be highly susceptible to hepatitis A virus.

Adolescent↗
PubMed1983

An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan.

In 1968-1981, a total of 3222 serum samples were collected from healthy subjects in Okinawa--in Ishigaki City, on Hateruma Island, and on Iriomote Island--and in Kyushu, in Fukuoka City and Nichinan City. These serum samples were tested for the presence of hepatitis B surface antigen (HBsAg) by reverse passive hemagglutination (RPHA), for antibody to hepatitis B surface antigen (anti-HBs) by passive hemagglutination (PHA) and radioimmunoassay (RIA), and for antibody to hepatitis B core antigen (anti-HBc) by RIA. Overall prevalence of HBsAg (7.5%), anti-HBs by PHA (41.0%) and RIA (56.4%), and anti-HBc (65.5%) in Okinawa was significantly higher than prevalence of HBsAg (2.4%), anti-HBs by PHA (24.7%) and by RIA (28.1%), and anti-HBc (30.9%) in Kyushu. In both areas, anti-HBc was more frequently detected than anti-HBs by both methods. In Okinawa, HBsAg was significantly more prevalent in males than in females. No significant differences by sex in other hepatitis B virus markers were found. On Iriomote Island and Ishigaki City, second samples were collected after intervals of 10 and 12 years, respectively. Over these periods, the prevalence of all hepatitis B virus markers decreased significantly for the 0-9 and 10-19 year age groups. These data suggest that hepatitis B infection among children has declined in recent years and that high prevalence of hepatitis B infection in adults may reflect high rates of infection in their childhood.

Adolescent↗